Difference between revisions of "External links"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(2 intermediate revisions by one other user not shown)
Line 84: Line 84:
 
*[http://www.nccn.org/professionals/physician_gls/f_guidelines.asp NCCN (National Comprehensive Cancer Network) clinical practice guidelines]
 
*[http://www.nccn.org/professionals/physician_gls/f_guidelines.asp NCCN (National Comprehensive Cancer Network) clinical practice guidelines]
 
*[http://www.uspreventiveservicestaskforce.org/adultrec.htm#cancer U.S. Preventive Services Task Force (USPSTF) cancer screening guidelines]
 
*[http://www.uspreventiveservicestaskforce.org/adultrec.htm#cancer U.S. Preventive Services Task Force (USPSTF) cancer screening guidelines]
*[https://www.guideline.gov/ National Guideline Clearinghouse]
+
*[https://www.guideline.gov/ National Guideline Clearinghouse] '''''Defunct since 2018'''''
 +
*[https://www.guidelinecentral.com/guidelines/ GuidelineCentral.com]
  
 
==[[Professional organizations|Hematology/Oncology & allied organizations]]==
 
==[[Professional organizations|Hematology/Oncology & allied organizations]]==
Line 118: Line 119:
 
*[http://www.cancerindex.org/geneweb/ Cancer GeneticsWeb]
 
*[http://www.cancerindex.org/geneweb/ Cancer GeneticsWeb]
 
*[http://cancergenome.nih.gov/ The Cancer Genome Atlas (TCGA)] at the National Cancer Institute (NCI)  
 
*[http://cancergenome.nih.gov/ The Cancer Genome Atlas (TCGA)] at the National Cancer Institute (NCI)  
*[http://www.cancerrxgene.org/ CancerRxGene.org] - Genomics of Drug Sensitivity in Cancer. Database & graphs of the responses of genes & cell lines to anti-cancer drugs.
+
*[http://www.cancerrxgene.org/ CancerRxGene.org] - Genomics of Drug Sensitivity in Cancer. Database & graphs of the responses of genes & cell lines to anti-cancer drugs.
 
*[http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC)] - Adverse event grading for clinical trials [https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0/ (FTP)]
 
*[http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC)] - Adverse event grading for clinical trials [https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0/ (FTP)]
 
:Version 5.0
 
:Version 5.0
Line 158: Line 159:
 
*[http://www.bloodjournal.org/collection/how-i-treat?sso-checked=true How I Treat (Blood Journal)]
 
*[http://www.bloodjournal.org/collection/how-i-treat?sso-checked=true How I Treat (Blood Journal)]
 
*[https://www.mypcnow.org/fast-fact-index Palliative Care Fast Facts - quick resource]
 
*[https://www.mypcnow.org/fast-fact-index Palliative Care Fast Facts - quick resource]
*[http://pinkbook.dfci.org/ DFCI / BWH Pain management / anti emetic references]  
+
*[http://pinkbook.dfci.org/ DFCI / BWH Pain management / anti emetic references]  
  
 +
[[Category:Evidence-based oncology]]
 
[[Category:General reference pages]]
 
[[Category:General reference pages]]

Revision as of 17:40, 1 March 2024

This list will need to be further organized in the future:

Clinical calculators & assessment tools

Diagnosis

Prognosis

Treatment dosing

Risks of treatment

Other

Education and Other Wikis

Guidelines & drug information

Hematology/Oncology & allied organizations

This link will take you to a page listing professional organizations that are relevant to hematologists, oncologists, and allied professionals.

Oncology-specific vendors

This link will take you to a page listing EHR vendors, analytics companies, and other oncology-specific commercially available products. Please note that inclusion on these lists is not an endorsement of the product, nor is exclusion a non-endorsement.

Patient & family information

Physician contact information

Research

Version 5.0
Version 4.0
  • Harvard Catalyst SHRINE - "web-based query tool that allows eligible investigators to determine the aggregate total number of patients at participating hospitals who meet a given set of inclusion and exclusion criteria"
  • My Cancer Genome - Information & clinical trials by mutation type

Staging

Statistics

Miscellaneous